311 results on '"LADENHEIM, BRUCE"'
Search Results
52. Neuronal Expression of Familial Parkinson's Disease A53T α-Synuclein Causes Early Motor Impairment, Reduced Anxiety and Potential Sleep Disturbances in Mice
53. Attenuated response to methamphetamine sensitization and deficits in motor learning and memory after selective deletion of β-catenin in dopamine neurons
54. Methamphetamine Causes Differential Alterations in Gene Expression and Patterns of Histone Acetylation/Hypoacetylation in the Rat Nucleus Accumbens
55. Chronic Methamphetamine Causes Differential Expression of Immediate Early Genes in the Nucleus Accumbens and Midbrain of Rats
56. Involvement of Dopamine Receptors in Binge Methamphetamine-Induced Activation of Endoplasmic Reticulum and Mitochondrial Stress Pathways
57. Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF
58. Chronic Methamphetamine Administration Causes Differential Regulation of Transcription Factors in the Rat Midbrain
59. Methamphetamine self‐administration alters gene expression in the rat striatum
60. Differential histone modifications induced by chronic methamphetamine exposure in the rat striatum
61. Methamphetamine-Induced Dopamine-Independent Alterations in Striatal Gene Expression in the 6-Hydroxydopamine Hemiparkinsonian Rats
62. Prenatal Interaction of Mutant DISC1 and Immune Activation Produces Adult Psychopathology
63. Monoamine Oxidases Regulate Telencephalic Neural Progenitors in Late Embryonic and Early Postnatal Development
64. Methamphetamine Preconditioning Causes Differential Changes in Striatal Transcriptional Responses to Large Doses of the Drug
65. Differential effects of methamphetamine and SCH23390 on the expression of members of IEG families of transcription factors in the rat striatum
66. Methamphetamine Self-Administration Is Associated with Persistent Biochemical Alterations in Striatal and Cortical Dopaminergic Terminals in the Rat
67. Methamphetamine Preconditioning Alters Midbrain Transcriptional Responses to Methamphetamine-Induced Injury in the Rat Striatum
68. Mice Lacking Multidrug Resistance Protein 1a Show Altered Dopaminergic Responses to Methylenedioxymethamphetamine (MDMA) in Striatum
69. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice
70. Methamphetamine Induces Dopamine D1 Receptor-Dependent Endoplasmic Reticulum Stress-Related Molecular Events in the Rat Striatum
71. Growth Factor Signals in Neural Cells
72. Environmental enrichment during adolescence regulates gene expression in the striatum of mice
73. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
74. Methamphetamine Administration Causes Death of Dopaminergic Neurons in the Mouse Olfactory Bulb
75. Neurotoxic doses of methamphetamine cause neurocognitive abnormalities in mice
76. Neuropeptide Y Protects against Methamphetamine-Induced Neuronal Apoptosis in the Mouse Striatum
77. Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria‐dependent pathway
78. Paroxetine retards disease onset and progression in Huntingtin mutant mice
79. Methamphetamine induces neuronal apoptosis via cross‐talks between endoplasmic reticulum and mitochondria‐dependent death cascades
80. Analysis of Ecstasy (MDMA)‐induced transcriptional responses in the rat cortex
81. Mice with Partial Deficiency of c-Jun Show Attenuation of Methamphetamine-Induced Neuronal Apoptosis
82. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
83. cDNA array analysis of gene expression profiles in the striata of wild‐type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine
84. Chronic cocaine increases κ‐opioid receptor density: Lack of effect by selective dopamine uptake inhibitors
85. Methamphetamine Causes Coordinate Regulation of Src, Cas, Crk, and the Jun N-Terminal Kinase–Jun Pathway
86. Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: Evidence from cDNA array analyses
87. Characterization of Human Cleaved N-CAM and Association with Schizophrenia
88. Methamphetamine increases expression of the apoptotic c-myc and l-myc genes in the mouse brain
89. Temporal profiling of methamphetamine‐induced changes in gene expression in the mouse brain: Evidence from cDNA array
90. Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage induced by a single high dose of methamphetamine: Examining the role of p53
91. Methamphetamine-Induced Neurotoxicity Is Attenuated in Transgenic Mice with a Null Mutation for Interleukin-6
92. Null Mutation of c-fos Causes Exacerbation of Methamphetamine-Induced Neurotoxicity
93. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine
94. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine
95. Effects of toxic doses of methamphetamine (METH) on dopamine D1 receptors in the mouse brain
96. Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice
97. Differential Reinforcing Effects of Cocaine and GBR-12909: Biochemical Evidence for Divergent Neuroadaptive Changes in the Mesolimbic Dopaminergic System
98. AP-1 DNA-binding activation by methamphetamine involves oxidative stress
99. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice
100. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.